MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1055-9965.epi-14-0429

Медицинская библиотека · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014

Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.

Parks Christine G, Miller Frederick W, Satoh Minoru, Chan Edward K L, Andrushchenko Zhanna, Birnbaum Linda S, Jusko Todd A, Kissling Grace E, Patel Mehul D, Rose Kathryn M, Weinberg Clarice, Zeldin Darryl C, Sandler Dale P

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Autoantibodies are of growing interest in cancer research as potential biomarkers; yet, the determinants of autoimmunity are not well understood. Antinuclear antibodies (ANA) are common in the general population and are more prevalent in women and older adults. Here, we examined the relationship of ANA with reproductive and hormonal factors in a representative sample of U.S. women.

METHODS

We analyzed data on reproductive history and exogenous hormone use in relation to serum ANA in 2,037 females ages 12 years and older from the National Health and Nutrition Examination Survey (NHANES; 1999-2004). Estimated ANA prevalences were adjusted for sampling weights. Prevalence ORs (POR) and 95% confidence intervals (CI) were adjusted for age, race, and poverty-income ratio, and models were stratified by menopause status.

RESULTS

In premenopausal women ages 20 years and older, ANA prevalence was associated with parity (P < 0.001; parous vs. nulliparous POR = 2.0; 95% CI, 1.2-3.4), but in parous women, ANA did not vary by number of births, age at first birth, years since last birth, or breastfeeding. In postmenopausal women, ANA prevalence was associated with an older age at menarche (P = 0.019; age 16-20 vs. 10-12 years POR = 3.0; 95% CI, 1.6-5.9), but not with parity. Oral contraceptives and estrogen therapy were not associated with a higher ANA prevalence.

CONCLUSIONS

Childbearing (having had one or more births) may explain age-associated elevations in ANA prevalence seen in premenopausal women.

IMPACT: These findings highlight the importance of considering reproductive history in studies of autoimmunity and cancer in women.

Для цитирования: Parks Christine G, Miller Frederick W, Satoh Minoru, Chan Edward K L, Andrushchenko Zhanna, Birnbaum Linda S, Jusko Todd A, Kissling Grace E, Patel Mehul D, Rose Kathryn M, Weinberg Clarice, Zeldin Darryl C, Sandler Dale P. Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014. DOI: 10.1158/1055-9965.epi-14-0429.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.